BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 20029386)

  • 21. TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
    Bagnoli S; Piaceri I; Tedde A; Bessi V; Bracco L; Sorbi S; Nacmias B
    Neurol Sci; 2013 Jun; 34(6):995-8. PubMed ID: 23546992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases.
    Soyal SM; Kwik M; Kalev O; Lenz S; Zara G; Strasser P; Patsch W; Weis S
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1317. PubMed ID: 32472747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Analysis of Polymorphisms in TOMM40, CR1, PVRL2, SORL1, PICALM, and 14q32.13 Regions in Colombian Alzheimer Disease Patients.
    Ortega-Rojas J; Morales L; Guerrero E; Arboleda-Bustos CE; Mejia A; Forero D; Lopez L; Pardo R; Arboleda G; Yunis J; Arboleda H
    Alzheimer Dis Assoc Disord; 2016; 30(4):305-309. PubMed ID: 27023435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patients.
    Helisalmi S; Hall A; Meriläinen EH; Väisänen V; Koivisto AM; Herukka SK; Laitinen M; Soininen H; Hiltunen M
    Neurodegener Dis; 2014; 14(4):204-8. PubMed ID: 25500937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes.
    Watts A; Wilkins HM; Michaelis E; Swerdlow RH
    J Alzheimers Dis; 2019; 70(4):1059-1068. PubMed ID: 31322569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial.
    Roses AD; Lutz MW; Crenshaw DG; Grossman I; Saunders AM; Gottschalk WK
    Alzheimers Dement; 2013 Mar; 9(2):132-6. PubMed ID: 23333464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population.
    Ortega-Rojas J; Arboleda-Bustos CE; Guerrero E; Neira J; Arboleda H
    Alzheimer Dis Assoc Disord; 2022 Jan-Mar 01; 36(1):29-35. PubMed ID: 35149606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SORL1 Polymorphisms in Mexican Patients with Alzheimer's Disease.
    Toral-Rios D; Ruiz-Sánchez E; Rodríguez NLM; Maury-Rosillo M; Rosas-Carrasco Ó; Becerril-Pérez F; Mena-Barranco F; Carvajal-García R; Silva-Adaya D; Delgado-Namorado Y; Ramos-Palacios G; Sánchez-Torres C; Campos-Peña V
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.
    Lutz MW; Crenshaw D; Welsh-Bohmer KA; Burns DK; Roses AD
    Curr Neurol Neurosci Rep; 2016 May; 16(5):48. PubMed ID: 27039903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease.
    Bakeberg MC; Hoes ME; Gorecki AM; Theunissen F; Pfaff AL; Kenna JE; Plunkett K; Kõks S; Akkari PA; Mastaglia FL; Anderton RS
    Sci Rep; 2021 Mar; 11(1):6363. PubMed ID: 33737565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
    Mastaglia FL; Rojana-udomsart A; James I; Needham M; Day TJ; Kiers L; Corbett JA; Saunders AM; Lutz MW; Roses AD;
    Neuromuscul Disord; 2013 Dec; 23(12):969-74. PubMed ID: 24103330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling APOE ɛ3/4 allele-associated sporadic Alzheimer's disease in an induced neuron.
    Kim H; Yoo J; Shin J; Chang Y; Jung J; Jo DG; Kim J; Jang W; Lengner CJ; Kim BS; Kim J
    Brain; 2017 Aug; 140(8):2193-2209. PubMed ID: 28899010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease.
    Chen SY; Chen TF; Lai LC; Chen JH; Sun Y; Wen LL; Yip PK; Chu YM; Chen YC
    J Neuroinflammation; 2012 Jan; 9():21. PubMed ID: 22272811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association and Gene-Gene Interactions Study of Late-Onset Alzheimer's Disease in the Russian Population.
    Bocharova A; Vagaitseva K; Marusin A; Zhukova N; Zhukova I; Minaycheva L; Makeeva O; Stepanov V
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.
    Bekris LM; Millard SP; Galloway NM; Vuletic S; Albers JJ; Li G; Galasko DR; DeCarli C; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Tsuang D; Peskind ER; Yu CE
    J Alzheimers Dis; 2008 Apr; 13(3):255-66. PubMed ID: 18430993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    Cardoso R; Lemos C; Oliveiros B; Almeida MR; Baldeiras I; Pereira CF; Santos A; Duro D; Vieira D; Santana I; Oliveira CR
    J Alzheimers Dis; 2020; 78(2):587-601. PubMed ID: 33016906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
    Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
    Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease.
    Kim YW; Al-Ramahi I; Koire A; Wilson SJ; Konecki DM; Mota S; Soleimani S; Botas J; Lichtarge O
    Alzheimers Dement; 2021 May; 17(5):831-846. PubMed ID: 33576571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population.
    Omoumi A; Fok A; Greenwood T; Sadovnick AD; Feldman HH; Hsiung GY
    Neurobiol Aging; 2014 Apr; 35(4):936.e5-12. PubMed ID: 24176626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.